Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
Top Cited Papers
- 1 April 2014
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 104, 153-155
- https://doi.org/10.1016/j.antiviral.2014.01.012
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus PolymerasePLOS ONE, 2013
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In VitroJournal of Virology, 2013
- Potential Vaccines and Post-Exposure Treatments for Filovirus InfectionsViruses, 2012
- Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic FeverPLoS Neglected Tropical Diseases, 2011
- Effect of T-705 treatment on western equine encephalitis in a mouse modelAntiviral Research, 2009
- Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106Antimicrobial Agents and Chemotherapy, 2009
- Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodentsAntiviral Research, 2008
- In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in MiceAntimicrobial Agents and Chemotherapy, 2007
- Mechanism of Action of T-705 against Influenza VirusAntimicrobial Agents and Chemotherapy, 2005